Bromsite Solution/ Drops
Product Images NDC 49708-754

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Bromsite (NDC 49708-754). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bromfenac Chemical Structure (Bromsite 01)

Bromfenac Chemical Structure (Bromsite 01)
FDA Label Image

Instructions For Use (Figure A)

Instructions For Use (Figure A)
FDA Label Image

Instructions For Use (Figure B)

Instructions For Use (Figure B)
FDA Label Image

Instructions For Use (Figure C)

Instructions For Use (Figure C)
FDA Label Image

Instructions For Use (Figure D)

Instructions For Use (Figure D)
FDA Label Image

Instructions For Use (Figure E)

Instructions For Use (Figure E)
FDA Label Image

Instructions For Use (Figure F)

Instructions For Use (Figure F)
FDA Label Image

5 mL Foil Wrapper (Bromsite 08)

5 mL Foil Wrapper (Bromsite 08)
FDA Label Image

5 mL Bottle Label (Bromsite 09)

5 mL Bottle Label (Bromsite 09)
This is a description of an ophthalmic solution with the active ingredient bromenacsdum. It is free of obraenac and comes in a bottle with the NDC code 49708-754-41. The lot number is AB12C34D and the expiration date is 01/10. There is additional text that is not readable.*
FDA Label Image

5 mL Carton Label (Bromsite 10)

5 mL Carton Label (Bromsite 10)
This is a description for a pharmaceutical product. It is an ophthalmic solution named "BromSITE" containing an active ingredient called "bromfenac sodium sesquihydrate" and other inactive ingredients such as "Sodium Citrate Poloxamer 407", "Pobcarbophi", "Sodium Chloride", and "Edetate Disodium". This product is intended for topical application into the eye and distributed by Sun Pharmaceutical Industries Inc. at Cranbury, NJ 08512. The recommended dosage is one drop into the affected eye twice per day beginning one day prior to the surgery. It comes in a sterile 5 mL container with a protective seal that should be discarded after treatment completion. The product should be kept in the original unopened container at 15°C-25°C, and it is for Rx only. The prescribing information is enclosed with the product.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.